Amicus Therapeutics to Engage Investors Through Key Conferences
Amicus Therapeutics to Engage Investors Through Key Conferences
Amicus Therapeutics has exciting plans to connect with investors through a series of important presentations scheduled for November. This initiative reflects the company’s dedication not only to advancing healthcare solutions for rare diseases but also to supporting its investor community.
Upcoming Investor Conferences
The company will be participating in the prestigious 2025 UBS Global Healthcare Conference, taking place in Palm Beach Gardens. This event is a key opportunity for Amicus Therapeutics to engage with investors, making a presentation on November 10.
What to Expect at UBS Conference
Management will kick off their presentation at 2:45 p.m. ET, providing insights into their innovative strategies and ongoing projects. This is a must-attend event for those interested in the future direction of the company.
Jefferies Global Healthcare Conference
Shortly after the UBS event, Amicus Therapeutics will take part in the Jefferies Global Healthcare Conference. This event, set for November 18, brings together key players in the healthcare sector from around the world.
Details for Jefferies Conference
Scheduled to begin at 4:30 p.m. GMT, this presentation represents another chance for the company to articulate its vision and present updates on its dynamic drug development pipeline.
Engaging Audiences Through Webcasts
For those unable to attend these conferences in person, Amicus will provide live audio webcasts, ensuring that a wider audience can gain insights into the company's progress. Interested individuals can access these presentations through the investor section of the Amicus Therapeutics corporate website.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is committed to being a leader in the biotechnology industry, developing innovative solutions for individuals with rare diseases. With a patient-centric focus, the company strives to enhance its portfolio with groundbreaking treatments that have the potential to change the lives of those affected by challenging conditions.
Company Objectives
The core mission of Amicus is to advance and expand its offerings, continuously pushing the boundaries of science to develop first- or best-in-class medicines. The company’s established reputation for prioritizing patient needs drives its ongoing research and development efforts.
Contact Information
For further inquiries or detailed information, investors can reach out to:
Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809
Media:
Amicus Therapeutics
Brendan McEvoy
Executive Director, External Communications
bmcevoy@amicusrx.com
(609) 662-5005
Frequently Asked Questions
What is the focus of Amicus Therapeutics?
Amicus Therapeutics specializes in developing novel high-quality medicines aimed at treating rare diseases.
When will Amicus Therapeutics present at conferences?
Amicus will present on November 10 at the UBS Global Healthcare Conference and on November 18 at the Jefferies Global Healthcare Conference.
How can investors access the presentations?
Investors can access the live audio webcasts through the investor section of the Amicus Therapeutics corporate website.
Who can be contacted for investor relations?
Andrew Faughnan, Vice President of Investor Relations at Amicus, is the main contact for investor inquiries.
What type of company is Amicus Therapeutics?
Amicus Therapeutics is a biotechnology company focused on delivering innovative treatments for individuals affected by rare diseases.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
